The University of Southampton

Are liposomes the future of cancer treatment?

According to the NHS, 1 in 2 people develop cancer at some point in their life. Unfortunately, I was able to see the devastating effects that chemotherapy and radiotherapy can have on a patient through my grandmother. Studying biomedical sciences incited me to research new technologies that are being developed in order to aid cancer treatments and I came across the use of nanoparticles but more specifically liposomes.

What are liposomes?

Liposomes are organic nanoparticles that are being widely studied by scientists, consisting of a bilayer of phospholipids that come together to form vesicles that are non-toxic, non-immunogenic and biodegradable. They have the ability to deliver active pharmaceutical ingredients by either encapsulating hydrophilic molecules inside the vesicle or by entrapping hydrophobic molecules in the lipid bilayer.

Not only do they have the ability to carry drugs but also can improve the delivery of antigens and other molecules to our immune cells, helping them destroy the cancer cells!

What characteristics make liposomes a good drug delivery system?

  1. Liposomes can deliver both hydrophilic and hydrophobic drugs, meaning that a large range of drugs can be delivered using them.
  2. They provide a protective layer around the drug which prevents degradation of the drug by the body and reduces the toxicity as the drug is not infecting the healthy cells in our body.
  3. The targeting of liposomes to cancer cells also increases the efficacy of the drug.
  4. Liposomes are biocompatible and biodegradable because they are made up of the same material as the membrane of cells, which minimises the risk of further side effects in our body.

So… what is the downside?

Up to this point, the use of liposomes sound like an amazing tool to be used in cancer research. However, scaling up the production of these liposomes makes it much more expensive than simply delivering chemotherapy to patients which could mean that people with less resources will not be able to pay for the treatments. Liposomes have a short shelf-life which means that if the drug has not reached the cancerous cells before this, the drugs will be delivered to healthy cells instead. Furthermore, they are susceptible to aggregations that can change their size and shape and possibly leading to unwanted drug release. The use of liposomes can also lead to hypersensitive or inflammation reactions, putting patients at risk.

Are these disadvantages much worse than the side effects caused by months of hospital visits in order to get chemotherapy and radiation?

Personal opinion

I believe that the idea of liposomes to be used for cancer treatment is one of the many amazing ideas that scientists are coming up with in order to improve the life of many. The use of liposomes in the field on oncology could have the potential to efficiently deliver drugs that are able to kill cancer cells and there are ongoing clinical trials for using them in certain types of cancer such as prostate cancer. However, I think that further improvements have to be made in order for this to be a safe and efficient drug delivery method we can use on humans. Scientists need to keep investigating the use of liposomes and also other nanoparticles in order to come up with a better solution to cancer than chemotherapy and radiation.

Ted talk from Joy Wolfram who talks about her research of nanoparticles in the field of oncology.

For further scientific readings on liposomes:

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879473/#:~:text=Compared%20with%20traditional%20drug%20delivery,and%20lower%20toxic%20side%20effects.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6017847/

A cool valve

When looking at University degrees, I came across Biomedical Engineering which immediately struck my attention as I love the idea that something you have built could potentially improve the life of many people. However, my lack of maths and physics understanding led me to choose a different degree.

One particular research that I found particularly interesting was something known as a Sapien transcatheter heart valve, which is a valve that can be introduced to the patient without the need of an open heart surgery.

The valve is introduced through the femoral artery and the inflation of a balloon allows it to be placed in the correct place in the heart, allowing patients without the ability to undergo complex procedures to obtain a new heart valve.